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The function of EZH2 as a transcription repressor is well characterized.
However, its role during vertebrate development is still poorly understood,
particularly in neurogenesis. Here, we uncover the role of EZH2 in controlling
the integrity of the neural tube and allowing proper progenitor proliferation.
We demonstrate that knocking down the EZH2 in chick embryo neural
tubes unexpectedly disrupts the neuroepithelium (NE) structure, correlating
with alteration of the Rho pathway, and reduces neural progenitor proli-
feration. Moreover, we use transcriptional profiling and functional assays to
show that EZH2-mediated repression of p21WAF1/CIP1 contributes to both
processes. Accordingly, overexpression of cytoplasmic p21WAF1/CIP1 induces
NE structural alterations and p21WAF1/CIP1 suppression rescues proliferation
defects and partially compensates for the structural alterations and the Rho
activity. Overall, our findings describe a new role of EZH2 in controlling the
NE integrity in the neural tube to allow proper progenitor proliferation.1. Introduction
Epigenetic factors are essential for tissue development and cellular homeostasis.
The major class of epigenetic regulators in developmental contexts is the
Polycomb group (PcG) proteins [1]. PcG proteins control gene expression
by keeping many developmental regulators silenced [2]. The hallmark for
Polycomb-mediated repression is methylation of lysine 27 of histone H3
(H3K27me3) [3,4], catalysed by Polycomb repressive complex 2 (PRC2) subunits
enhancer of zeste homologues 1 and 2 (EZH1/2) [3,5–8]. While EZH1 is predo-
minant in differentiated tissue, EZH2 is highly expressed in proliferating cells,
such as embryonic and adult neural progenitors [8–13], and in a wide variety of
cancer cells [14,15]. PRC2 is required for proper differentiationof embryonic stem
cells (ESCs) and somatic stem cells [8,12]. There, EZH2 controls cell proliferation
in part by regulation of the Ink4A/Arf locus [12]. In addition, EZH2 can control
cofilin activity and, consequently, the actin cytoskeleton structure that regulates
the expression of integrin alpha 2 in colon cancer cells [16]. In addition to its role
as an epigenetic factor, EZH2 cooperates with different signals to allow actin
reorganization and proliferation [17].
The previous data show that the function of EZH2 as a transcription repressor
is well characterized. However, its role during vertebrate development is still
poorly understood, particularly in neurogenesis. Several models have been gen-
erated to study the role of PRC2 during neural development [18,19]. We know
that, at the onset of neurogenesis, conditional deletion of EZH2 in the cerebral
cortex shifts the balance between self-renewal and differentiation towards the
latter [19]. This leads to a decreased number of neurons at birth. By contrast, it
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Figure 1. EZH2 depletion leads to small and structurally disorganized neural tubes. (a) Diagrams show regions occupied by proliferating neural progenitors (ven-
tricular zone, VZ) and post-mitotic neurons (mantle zone, MZ) in HH10 (only progenitors) and HH30 chick embryo spinal cord (left panel). HH30 wild-type embryo
neural tubes were immunostained using anti-EZH2 antibody (right panel). (b) Ten HH10 or HH30 embryo neural tubes were dissected out for each replicate. mRNA
was extracted and retrotranscribed for qPCR analysis. The graph shows EZH2 mRNA, normalized by GAPDH mRNA levels. Results are means of three independent
experiments. Error bars indicate s.d. *p, 0.05. (c) HH11–12 embryos were co-electroporated with a mixture of shRNA-EZH2(1) and shRNA-EZH2(2) (shEZH2) or
shRNA-control (shCtrl) cloned into pSHIN vector expressing GFP. Transversal sections of electroporated neural tubes as indicated above stained with DAPI 48 h PE.
Graphs show the quantification of the size of the control side and shEZH2-electroporated side. To do that, we measured the dorsal, medial and ventral distances to
the lumen on each side, relative to the length of the central line of the lumen. Data represent mean of n ¼ 10–20 sections (from three to five embryos). Error bars
indicate s.d. **p, 0.01; ***p, 0.001. (d– f ) Transversal sections of neural tubes from HH11–12 embryos electroporated in ovo with shCtrl or shEZH2 and
stained for H3S10p (d ), Sox5 (e) or caspase 3 ( f ) 48 h PE. Graphs show the quantification of the corresponding immunostaining. Data represent mean of
n ¼ 20–30 sections (from four to six embryos). Error bars indicate s.d. *p , 0.05; **p , 0.01; ***p, 0.001.
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cursors results in an increased number of neurons [18]. These
data indicate that EZH2 has a strict timing-dependent role in
neurogenesis, but do not fully clarify the role of PRC2 in
early neural development. To explore the potential contri-
bution of PRC2 to event coordination during this stage, we
analysed the consequences of EZH2 depletion in chick
embryo spinal cord. We found that knocking down EZH2 in
neural progenitors disrupts the neuroepithelium (NE) struc-
ture and reduces their proliferation capacity. In addition, we
observed that p21WAF1/CIP1 repression by EZH2 contributes
to both processes. Our data demonstrate that EZH2 is neces-
sary to maintain the NE integrity, allowing proliferation of
neuroepithelial cells in the neural tube.2. Results
2.1. EZH2 is required for neural progenitor proliferation
and survival
EZH2 is highly expressed in the ventricular zone (VZ, formed
by neural progenitors) of the developing chick spinal
cord (figure 1a). Moreover, we observed that its expression
decreased inHamburger andHamilton (HH) stage 30 embryos,
where the mantle zone (MZ, formed by neurons) is pre-
dominant, compared with HH10 embryos (figure 1a,b).
These observations led us to study whether PRC2 complex
is required during early stages of neurogenesis. For this pur-
pose, we knocked down EZH2 expression in HH 11–12 chick
embryo spinal cords, by in ovo electroporation of two distinctnon-overlapping short hairpin (sh)RNAs (shEZH2(1) or
shEZH2(2), see sequences in Material and Methods section)
that efficiently reduced EZH2 levels (electronic supplementary
material, figure S1a), or a control shRNA (shCtrl). Remarkably,
EZH2 knock down resulted in a small and structurally disorga-
nized neural tube (electronic supplementary material, figure
S1b). As the two independent shRNA-EZH2 sequences gave
similar phenotypes, we co-electroporated both shEZH2(1)
and shEZH2(2) sequences (that we named shEZH2) in the
remaining experiments. As expected, this process efficiently
decreased the EZH2 RNA (electronic supplementary material,
figure S1c) and protein levels (55%) (electronic supplementary
material, figure S1d) 48 h post-electroporation (PE), and
resulted in a reduction of the electroporated side and a disorga-
nized neural tube (figure 1c). At an earlier time (24 h PE), lower
EZH2 reduction (30%) was observed (data not shown). Thus,
we decided to perform the rest of the analysis at 48 h PE.
To further investigate shEZH2 specificity, we performed
rescue experiments overexpressing human EZH2 (rEZH2),
which is not targeted by chicken shEZH2. The data in the elec-
tronic supplementary material, figure S1e show the rescue of
both the size and morphological alterations of the neural tube
after electroporation of the rEZH2 plasmid, demonstrating the
specificity of the shEZH2.
As EZH2 is the catalytic subunit of PRC2, we assessed if
EZH2 depletion affected global H3K27me3 levels. Immuno-
staining assays showed no changes in global H3K27me3
(electronic supplementary material, figure S2a), which might
be explained by an increase of EZH1 after EZH2 depletion
(electronic supplementary material, figure S2b). We further
analysed the contribution of H3K27me3 mediation in the role
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rEZH2 mutated at the catalytic SET domain that lacks histone
methyltransferase (HMT) activity. The results indicated
that neither the size nor the morphological alterations of the
neural tube were rescued to the same extent as in the EZH2
wild-type (electronic supplementary material, figure S2c).
These data suggest that H3K27me3 or methylation of an
unknown substrate contributes to the described phenotype.
The role of EZH2 in proliferation has beenwell characterized
in ESCs [12,14,20,21]. On this basis, we hypothesized that
the reduced size of shEZH2-electroporated neural tubes might
reflect an active role of EZH2 in the maintenance of neural
progenitor proliferation, following a previous proposal [19].
To confirm this, we electroporated HH11–12 neural tubes
with shEZH2 or shCtrl and analysed the effect on neural pro-
genitor proliferation after 48 h. We evaluated the entry of
neural progenitors into the S phase of the cell cycle, analysing
bromodeoxyuridine (BrdU) incorporation. In the electronic
supplementary material, figure S3a, we show that shEZH2-
electroporated cells (green fluorescent protein (GFPþ)) incorpor-
ated less BrdU than those electroporatedwith shCtrl (percentage
of BrdUþGFPþ/total GFPþ cells: shCtrl 19.4+6.1%, shEZH2
11.5+4.9%; p, 0.01). Accordingly, neural tubes electroporated
with shEZH2 showed a reduction in H3S10p-positive mitotic
cells (ratio of H3S10pþ cells electroporated (EP) side/control
side: shCtrl 1.02+0.26, shEZH2 0.46+0.18; p, 0.001)
(figure 1d). Finally, reduction of the neural progenitor marker
SOX5 (ratio of SOX5þ cells EP side/control side: shCtrl 0.97+
0.07, shEZH2 0.22+0.08; p, 0.001) (figure 1e) suggests that
EZH2 is required for neural progenitor self-renewal in the
neural tube.
As a growing number of studies demonstrate that PcG pro-
teins are required at promoters of many neurogenesis-specific
genes [22,23], we then decided to explore if inhibition of
proliferationuponEZH2 reduction correspondedwith aprema-
ture differentiation of neuroblasts. We found that neural tubes
electroporated in ovowith shEZH2and stained for Tuj1, a neuro-
nal differentiation marker, showed premature differentiation
and an ectopic localization at 48 h PE (electronic supplementary
material, figure S3b). However, we did not observe an increase
in the number of differentiated neurons (ratio of Tuj-1þ cells
EP side/control side: shCtrl 0.95+0.09, shEZH2 0.90+0.08).
Next, we tested the presence of cellular death after EZH2
depletion. By active caspase 3 immunostaining, we observed a
higher number of apoptotic cells in the shEZH2-electroporated
side of the neural tube than in the shCtrl-electroporated side
(ratio of caspase 3þ cells EP side/control side: shCtrl 2+3.95,
shEZH2 14.1+5.1; p, 0.01; figure 1f ).
Finally, we showed that shEZH2-electroporated embryos
display ectopic mitotic cells far from the apical membrane,
their typical location inwild-type embryos (figure 1d, indicated
by arrows). This result suggests either an incomplete interki-
netic nuclear movement or a consequence of the ectopic
formation of new apical membrane-like structures (see below).
Taken together, these results indicate than EZH2 is essen-
tial to preserve the NE structure of the neural tube and to
maintain proliferation and survival of neural progenitor cells.
2.2. EZH2 preserves NE structure
Our data above demonstrate that shEZH2 electroporation
altered NE morphology and organization. Considering that
this is a totally new EZH2-related phenotype we furthercharacterized the nature of the observed alterations. We immu-
nostained electroporated neural tubes with phalloidin, which
stains fibrillar actin. After shEZH2 electroporation, a subset of
cells lost the apical junctions and invaded the neural tube
lumen (figure 2a,c white arrows and d; also figure 1c, left
panel) (percentage of EP neural tubes with lumen invasion:
shCtrl 1%, shEZH2 45%). In addition, ectopic lumens were
observed in the electroporated side of the neural tube (amplified
in figure 2a andquantified in figure 2d) (percentage of EPneural
tubes with ectopic lumens: shCtrl 0%, shEZH2 70%). Interest-
ingly, the ectopic lumens were functional, as suggested by the
mitotic divisions that took place at these new apical surfaces
(electronic supplementary material, figure S3c and figure 1d,
yellow arrows). These data suggest that the observed NE mor-
phological alterations are related to defects in the apicobasal
polarity. Interestingly, these effects were partially reverted
after electroporation of rEZH2 (electronic supplementary
material, figure S1e); however, no rescue was observed when
using the catalytic mutant rEZH2DSET (electronic supplemen-
tary material figure S2c). To test this hypothesis, shEZH2 and
shCtrl neural tubeswere immunostained for aPKC, a basic com-
ponent of the apical complex. Results in figure 2b,d and
electronic supplementary material, figure S3d indicated that,
after EZH2 depletion, the apical membrane was severely dis-
rupted along the luminal surface (percentage of EP neural
tubes with breakage of apical membrane: shCtrl 1%, shEZH2
67.5%), confirming the creation of new ectopic lumens (ampli-
fied in figure 2b). We know that, in addition to the apical
complex, the integrity of the apical membrane requires a correct
distribution of adherens junction (AJ) components. Therefore,
we decided to analyse the distribution of N-cadherin after
shEZH2 electroporation and found, after AJ protein immunos-
taining, that the apical membrane was disrupted (figure 2c,
green arrow) and that some progenitors had lost the apicobasal
polarity and had occupied the lumen (figure 2c, white arrow).
It has been proposed that EZH2 regulates actin polymeriz-
ation by interacting with vav1, an activator of RhoA GTPase
signalling [27], a pathway that couples developmental signals
and downstream cytoskeletal rearrangements [28,29] and is
repressed in the neural tubes at the analysed stages [30,31].
This gives us the rationale to explore the possibility that EZH2
depletion could affect Rho activity at the early stages of neuro-
genesis. To do this, we analysed Rho activity in EZH2-
depleted or control embryos on thewidely used serum response
element (SRE) fused to luciferasegene reporter [24–26]. Figure2e
shows higher levels of luciferase activity in EZH2-depleted
embryos, indicating an increase in Rho activity. Moreover, we
observed higher levels of phosphorylated paxilin, a well-
known Rho target [32], in shEZH2-electroporated embryos
(figure 2f ), suggesting that EZH2 depletion correlates with
alteration of the Rho activity in the chick embryo neural tube.
2.3. EZH2 targets p21WAF1/CIP1 promoter
To gain insight into the role of EZH2 in early neurogenesis,
we analysed the transcriptional profiling of fluorescence-
activated cell sorting (FACS)-purified GFPþ cells, from
shEZH2 and shCtrl-electroporated neural tubes (figure 3a).
We identified 462 genes that significantly changed their
expression (fold change (FC). 1.5 and p-value, 0.05) in
shEZH2 samples (see Material and methods section). This
result was validated by qPCR analysis of 14 randomly
chosen genes (figure 3b). Interestingly, the proportion of
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Figure 2. EZH2 preserves NE structure. (a– c) Transversal sections of neural tubes from HH11–12 embryos electroporated in ovo with shCtrl or shEZH2 and stained with
phalloidin-rhodamine (a), aPKC (b) or N-cadherin (N-CAD, c) antibodies and DAPI 48 h PE. The results are representative of at least four independent experiments. White
arrows mark progenitor cells that have lost the apicobasal polarity and have occupied the lumen. Green arrow indicates area where the apical membrane was severely
disrupted along the luminal surface. (d ) Graph shows the quantification of the morphological alterations observed in electroporated neural tubes. Data represent the
percentage of n ¼ 51 sections ( from three to four embryos). (e) HH11–12 embryos were electroporated in ovo with shCtrl or shEZH2 together with pSRE-luc plasmid
[24–26] and b-gal reporter used as internal control; 48 h PE the neural tubes were dissected out, the tissue was disaggregated and the luciferase activity measured
using the Life Technologies dual kit. Data represent mean of three experiments from five to seven embryos. Error bars indicate s.d. ***p , 0.001. ( f ) HH11–12
embryos were electroporated in ovo with shCtrl or shEZH2; 48 h later GFPþ neural cells were FACS purified. Total protein extracts were prepared and the levels of
paxillin ( pY31) were determined by western blot. b-Tubulin levels were used to normalize the protein content.
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similar. However, the genes with a higher FC were predomi-
nantly upregulated (figure 3c), in accordance with the
repressor role described for EZH2. Gene ontology analysis
revealed that genes misexpressed by EZH2 depletion were fre-
quently associated with cell proliferation, cell adhesion and
apoptosis regulatory processes, among others (figure 3d). Inter-
estingly, we observed the increase of a Rho family member,
RhoBTB2, as well as a decrease of the Rho inhibitory factor
ARHGAP10 that could contribute to the observed increased
Rho activity. Moreover, changes in the expression of other
genes involved in actin cytoskeleton and apicobasal polarity
such as SDK2, FZD3, FN1, NINJ1, NELL2 and NINJ2 were
identified. We also found that p21WAF1/CIP1, a well-known
tumour suppressor gene and regulator of the Rho pathway,
was highly upregulated (figure 3b).
Given that p21WAF1/CIP1 expression is undetectable in the
VZ of the neural tube at the analysed developmental stages
(figure 4a), we postulated that EZH2 directly regulates
p21WAF1/CIP1 expression at this stage of development. We first
confirmed its increase by in situ hybridization (ISH) of
HH11–12 embryo transverse sections of EZH2-depleted
embryos. Results showed that p21WAF1/CIP1 mRNA washighly induced after EZH2 depletion (figure 4a). Next, we ana-
lysed the activity of p21WAF1/CIP1 promoter fused to a luciferase
reporter in control and EZH2-depleted chick embryo neural
tubes. As inferred by the results shown in figure 4b, EZH2
represses p21WAF1/CIP1 promoter, either directly or indirectly,
at the analysed developmental stages. Finally, we used chroma-
tin immunoprecipitation (ChIP) experiments to test if this
promoter was directly targeted by EZH2. In addition to
p21WAF1/CIP1, we also analysed NeuroD1 and Hes5 promoters.
Hes5 was used as a negative control of ChIPs, because it is
highly expressed in neural tubes [33] and, for this reason, unli-
kely to be a target of EZH2. NeuroD1 was used as a positive
control, as it is repressed at the analysed stages [33] and is a
known H3K27me3 target in stem cells [22,34]. Figure 4c
showed that p21WAF1/CIP1 promoter was enriched in EZH2 at
neural tubes. This enrichment was smaller than in the
NeuroD1 promoter; as expected, EZH2 was not detected at
the Hes5 promoter (figure 4c).
To examine whether changes in p21WAF1/CIP1 expression
were directly associated with EZH2 levels, we used ChIP
assays at p21WAF1/CIP1, NeuroD1 and Hes5 promoters after
in ovo electroporation with shCtrl or shEZH2. In figure 4c,
left panel, we show that, after EZH2 depletion, EZH2 levels
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Figure 3. EZH2 regulates genes involved in proliferation and NE structure. (a) Schematic of microarray analysis design. (b) Relative mRNA levels were analysed for
the indicated genes by qPCR in control (shCtrl) and EZH2-depleted cells (shEZH2) from electroporated neural tubes. Data represent mean of three independent
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(5.9+ 0.9-fold) promoters. These data suggest that p21WAF1/
CIP1 is directly repressed by EZH2 in the chick embryo
neural tube, at the analysed developmental stages.
As EZH2 is the catalytic subunit of PRC2, we assessed if
p21WAF1/CIP1 promoter is trimethylated at H3K27 and if this
mark changes upon EZH2 depletion, using ChIP assays. We
found (figure 4c, right panel) that the p21WAF1/CIP1 promoter
was enriched in H3K27me3 at HH25 neural tubes. This enrich-
ment was clearly smaller than in the NeuroD1 promoter, but
higher than in the Hes5 promoter. Interestingly, this histone
modification decreased (45%+0.1) upon EZH2 depletion
and correlated with p21WAF1/CIP1 promoter activation
(figure 4a,b). These data suggest that EZH2-mediated
H3K27me3 might regulate the expression of p21WAF1/CIP1
gene at the analysed developmental stages.2.4. EZH2-mediated repression of p21WAF1/CIP1
contributes to NE integrity
Next, we analysed to what extent p21WAF1/CIP1 derepression
was responsible for the shEZH2-induced phenotype. To inves-
tigate if restoration of p21WAF1/CIP1 levels in shEZH2 embryos
affects the final phenotype, we co-electroporated neural tubes
with shEZH2 and an shRNA against p21WAF1/CIP1 (shp21),
which efficiently reduced the p21WAF1/CIP1 levels (figure 5a).
Then, we analysed BrdU incorporation and H3S10p signals
by immunostaining assays. Interestingly, the proliferation
defects observed by depletion of EZH2 were rescued upon
co-electroporation of shp21 (figure 5b,f, electronic supplemen-
tary material, figure S4a) (percentage of BrdUþGFPþ/total
GFPþ cells: shCtrl 19.4+6.1%, shEZH2 11.5+4.9%;
shEZH2þ shp21 22.6+8.1%); percentage of H3S10pþ cellsEP side/control side: shCtrl 0.97+0.1%, shEZH2 0.41+0.19%;
shEZH2þ shp21 0.83+0.19%).
Although the neural progenitors proliferated normally
upon shEZH2 and shp21 co-electroporation, the caspase 3
levels remained high (difference of caspase 3þ cells EP side/
control side: shCtrl 1+0.7%, shEZH2 10.8+8.8%;
shEZH2 þ shp21 9.5+8.2%; figure 5c,f ). This suggests that
p21WAF1/CIP1 is not the main factor driving cell death after
EZH2 depletion. Therefore, the survival phenotype induced
by low levels of EZH2 was independent from the proliferation
defects influenced by p21WAF1/CIP1 misregulation. Consistent
with this, data from expression microarrays identified some
genes (Fas, SesN1 and ZBTB38) directly involved in apoptosis
that could be responsible for the observed phenotype.
We next examined if upregulation of p21WAF1/CIP1 also con-
tributes to the observed NE structural defects. With this aim,
we analysed NE polarity with two apical and AJ markers
(actin and N-cadherin). The data in figure 5d,e,f demonstrated
that decreasing the p21WAF1/CIP1 levels partially (52%) rescued
NE structural defects.
To discard proliferation and differentiation effects
mediated by the nuclear p21WAF1/CIP1 in this regulation, we
tested the phenotype resulting after electroporation of a
p21WAF1/CIP1mutant. This mutant lacks the nuclear localization
signal (NLS) (p21-DNLS) and localizes mainly in the cyto-
plasm (electronic supplementary material, figure S4b) [35].
We observed that electroporation of p21WAF1/CIP1 induced cell
cycle leave but not alteration of the NE structure. However,
electroporation of cytoplasmic p21WAF1/CIP1 (but not the
nuclear p21WAF1/CIP1) in chick embryo neural tube induced
the formation of ectopic and functional lumens. These were
similar, but milder, to those observed in EZH2-depleted
neural tubes (figure 5g, yellow arrows). Moreover, electropora-
tion of another factor, Smad3 constitutively active, that induces
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in the neural tube [36], did not affect the NE structure (elec-
tronic supplementary material, figure S4c), suggesting that
p21WAF1/CIP1 by itself, and not indirect effects derived from
its increase, contributes to NE integrity. These data proved
that EZH2-mediated repression of p21WAF1/CIP1 by itself is
important for both the NE integrity and progenitor
proliferation. Next, we tested whether p21WAF1/CIP1 could be
involved in the observed Rho regulation in the neural tube.
With this goal in mind, we measured the activity levels of
SRE in shEZH2–shp21 co-electroporated embryos. In
figure 5h, we show that depletion of p21WAF1/CIP1 partially res-
cued the increase on SRE activity induced by shEZH2 in the
embryos. Additionally, overexpression of p21WAF1/CIP1 strongly
synergized with RhoA, to activate the SRE promoter in the
293 T cell line (figure 5i). These results suggest that the increasein Rho activity that correlates with EZH2 depletion was partly
due to p21WAF1/CIP1.
Altogether, our results strongly suggest that EZH2 is
essential to maintain neural tube homeostasis at early
stages of vertebrate development.3. Discussion
In this work, we demonstrate that EZH2 plays an essential role
in vertebrate neurogenesis, using chick embryo spinal cord as a
model. Our results revealed an unexpected role of EZH2 in
controlling NE structure and integrity. We demonstrated that
EZH2-depleted neural tubes lost the apicobasal polarity, and
their morphological structure was altered. In addition, EZH2-
depleted neural tubes were smaller than control neural tubes,
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apoptosis. Transcriptional and functional analysis confirmed
that EZH2-mediated repression of p21WAF1/CIP1 contributes to
both NE integrity and proliferation.
3.1. Role of EZH2-mediated H3K27 methylation
Our results demonstrated that p21WAF1/CIP1 expression
induced by EZH2 depletion correlated with changes in
H3K27 methylation at the promoter. Interestingly, we have
not observed global changes on H3K27 methylation. A poss-
ible explanation of this result is that EZH1, whose expression
increases after EZH2 depletion, partially replaces EZH2 at
many but not all places in the genome, as has been
proposed [37]. Thus, global H3K27me3 levels not always
reflect the methylation/demethylation dynamics at a particu-
lar locus. Similar results have been shown for other chromatin
regulators [38–40]. These results suggest that local changes in
H3K27me3 at promoters drive the observed phenotype. In
addition, the fact that EZH2DSET did not rescue it reinforcesthe idea that EZH2 catalytic activity on histone H3, or other
substrates [41], is essential in early neurogenesis. Moreover,
apart from its nuclear role, EZH2 cooperates with different
signals to allow actin reorganization and proliferation [17].
All these published data suggest that EZH2 is a very versatile
protein which could operate during early neurogenesis.
Further characterization of the HMT-dependent and
HMT-independent activities may reveal novel regulatory
mechanisms of EZH2.
3.2. EZH2 and proliferation
Regarding the requirement of EZH2 for neural progenitor
proliferation, our findings reveal notable differences in the
observed mechanism by which PRC2 complex promotes pro-
liferation in ESCc and cancer cells [12,14,20]. In this
mechanism, EZH2 increases H3K27me3 levels in the Ink4/
Arf locus, to inhibit the transcription of p16INK4A and
p19ARF, which induces cell-cycle progression. We observed
that the truncated chicken Ink4/Arf locus [42] was not
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reason, we believe that this is an excellent model to identify
new EZH2 targets involved in the regulation of neural
progenitor proliferation. Our data revealed that EZH2-
mediated regulation of a key inhibitor of the G1 to S tran-
sition, p21WAF1/CIP1, contributes to neural progenitor
homeostasis. Interestingly, p21WAF1/CIP1 has been shown to
be regulated by Bmi-1, a member of the PRC1 complex, in
neural stem cells to control cell renewal [43]. Considering
that some promoters or genomic sites can recruit either one
or/and the other PRC complex [44], it would be interesting
to investigate whether Bmi-1 is directly involved in the
repression of p21WAF1/CIP1 promoter in the absence of EZH2.
On the other hand, it could be possible that both complexes,
PRC1 and PRC2, collaborate to regulate p21WAF1/CIP1 promoter.
In this case, it could be important to analyse the contribution of
H3K27me3 and H2AK119 ubiquitination to this promoter
activity. Our data strongly indicated that EZH2 directly targets
p21WAF1/CIP1 promoter in neural progenitors and that its
activity correlates with changes in H3K27me3 levels. Whether
PRC1 complex recognizes and binds to H3K27me3 at this
promoter in neural progenitors is still an open question.
3.3. EZH2 and neural tube structure
Our results demonstrate that EZH2 depletion correlates with
alteration of the Rho pathway. In agreement with this idea, it
has been proposed that EZH2 regulates actin polymerization
by interacting with vav1, an activator of RhoA GTPase
signalling [27]. Moreover, EZH2 directly represses DLC1
(deleted in liver cancer 1), a GTPase-activating protein of the
Rho family proteins, implicated in actin cytoskeleton reorganiz-
ation [45]. More recently, it has been shown that EZH2
controls cofilin activity and consequently the actin cytoskeleton,
regulating integrin alpha 2 expression in colon cancer cells [16].
On the other hand, there are several reports demonstrat-
ing the importance of Rho GTPases in the preservation of
NE integrity in chick embryo neural tube [46]. In particular,
a critical role of RhoA in the maintenance of apical AJs and
the regulation of neural progenitor proliferation has been
described in developing mammalian brain [47]. Interestingly,
Rho accumulates apically in developing chick neural tube
and is subjected to a strict spatio-temporal regulation [48].
In fact, both disruption and continuous activation of Rho
activity altered neural tube formation and morphology [48].
One naturally wonders how EZH2 regulates Rho activity in
the neural tube. We are still far from a complete understanding
of this regulation; however, our data suggest that EZH2 contrib-
utes to maintaining proper Rho levels during neural tube
development. Further experiments are required to totally clarify
whether EZH2 directly represses Rho-related genes during
neural development or/and non-transcriptional effects are
also involved. Interestingly, inmunostaining experiments
performed in our laboratory indicate that EZH2 has a cyto-
plasmic location at the ventricular zone of the neural tube
(data not shown), suggesting a potential transcriptional-
independent contribution of EZH2 to the observed phenotype.
3.4. EZH2 in development
Recently, it has been shown that senescence occurs
during embryonic development at multiple locations, in a
p21WAF1/CIP1-dependent manner, and independent of p53and other cell-cycle regulators promoting tissue remodelling
[49,50]. On the other hand, it has been proposed that EZH2
regulates senescence in different biological contexts such as
cancer [20,51] or in primary cells [52]. These observations pro-
vided us with a rationale to propose that EZH2 could regulate
senescence at early stages of neural development, through
p21WAF1/CIP1 repression. Accordingly, preliminary data from
our laboratory show an intense senescence in the neural tube,
mainly in the MZ where the EZH2 expression decreases.
Therefore, EZH2-mediated p21WAF1/CIP1 repression might be
essential to maintain a proper NE structure and morphology
at early stages of neurogenesis.
In summary, our findings contribute to clarify the function
of EZH2 during the development of the nervous system,
revealing a new function for this epigenetic regulator.4. Material and Methods
4.1. Plasmids and recombinant proteins
DNA sequences coding two EZH2 and p21WAF1/CIP1 shRNAs
were cloned into pSHIN vector [53] that contains the pSUPER
shRNA expression cassette and another expression cassette for
EGFP. Human EZH2 (rEZH2) and its deleted form lacking the
SET domain (amino acids 622–707) cloned into pCIG vector
[54] have been previously described [33]. p21WAF1/CIP1,
p21WAF1/CIP1 DNLS expression vectors and p21WAF1/CIP1 promo-
ter fused to luciferase reporter were a gift fromDrN.Agell [35].
pCIG-Smad3S/Dwas kindly provided byDr E.Martı´ [36]. The
5XSRE fused to the luciferase-reporter gene was kindly given
by Dr A. Aragay.
4.2. Primers for shRNAs
ChickEZH2(1)fw:
GATCCCCCAGACTCTCAATGCTGTTGCTTCAAGAGA
GCAACAGCATTGAGAGTCTTTTTTGGAAA
ChickEZH2(1)rw:
AGCTTTTCCAAAAAAGACTCTCAATGCTGTTGCTCTCT
TGAAGCAACAGCATTGAGAGTC TGGG
ChickEZH2(2)fw:
GATCCCCCCAACGTAGGATACAGCCTGTTCAAGAGAG
TTGCATCCTATGTCGGACTTTTTGGAAA
ChickEZH2(2)rw:
AGCTTTTCCAAAAACAACGTAGGATACAGCCTGTCTCT
TGAAGTTGCATCCTAT GTCGGACGGG
Chickp21WAF1/CIP1fw:
GATCCCCGCAGACCACCATCAAAGACTTCAAGAGACG
TCTGGTGGTAGTTTCTGTTTTTGGAAA
Chickp21WAF1/CIP1rw:
AGCTTTTCCAAAAAGCAGACCACCATCAAAGACTCTCT
TGAACGTCTGGTGGTAGTTTC TGGGG
4.3. Antibodies
The following antibodies were used: anti-BrdU (Hybridoma
Bank); anti-mouse b-tubulin III (Tuj1, Covance, MMS-435P);
anti-H3S10p (Upstate); anti-caspase 3 (BD PharMingen);
anti-N-cadherin (DSHB); anti-trimethyl H3K27 (Millipore);
anti-EZH2 (Zymed and Active motif); anti-aPKC (Santa Cruz,
sc-17781); anti-b-tubulin (Millipore, MAB3408); anti-SOX5
(kindly provided by Dr Morales [55]; anti-pY31 paxillin
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(Sigma, P1951).
4.4. Fluorescence-activated cell sorting
Electroporated embryos were dissected out 48 h PE and
trypsinized for 5–10 min in 0.5% trypsin-EDTA (Sigma).
Trypsinization was stopped by 20% horse serum in PBS
20.1% glucose solution. GFPþ cells from the suspension
were sorted by flow cytometry using a MoFlo flow cytometer
(DakoCytomation, Fort Collins, CO, USA).
4.5. Chick in ovo electroporation
Eggs from White-Leghorn chickens were incubated at 38.58C
and 70% humidity. Embryos were staged following HH [56].
Embryos were electroporated with purified plasmid DNA at
0.25–3 mg ml21 in H2O with 50 ng ml
21 of fast Green. Plasmid
DNAwas injected into the lumen of embryos, electrodes were
placed at both sides of the neural tube and embryos were elec-
troporated by an IntracelDual Pulse (TSS-100) electroporator
delivering five 50 ms square pulses of 20–25 V. Electroporated
embryos were allowed to develop for 24 h or 48 h and then
dissected out and processed for the appropriate protocol.
4.6. Indirect immunofluorescence
The brachial regions of the embryos were collected and fixed
for 2 h at 48C in 4% paraformaldehyde. They were then
rinsed, embedded in 5% agarose–10% sacarose for sectioning
in a Leica vibratome, or immersed in PBS 30% sucrose solution
and embedded in OCT for sectioning in a Leica cryostat (CM
1900). Sections were blocked at room temperature for 1 h in
1% bovine serum albumin (in PBS with 0.1% Triton-X) before
overnight incubation at 48C with primary antibodies. Finally,
sections were incubated for 2 h at room temperature with
Alexa-conjugated goat secondary IgG antibodies (Jackson
Immuno Research Inc.) and 0.1 ng ml21 DAPI (Sigma).
Images were captured by a Leica SP5 confocal microscope
using LAS-AF software.
4.7. In situ hybridization
Whole-mount embryo RNA ISHwas done following standard
procedures using EST bank probes for chick p21WAF1/CIP1. After
hybridization, embryos were post-fixed in 4% paraformalde-
hyde for 2 h, embedded in 10% sucrose, 5% agarose solution
and sectioned in a Leica vibratome (VT 1000S).
4.8. mRNA extraction and quantitative PCR
mRNA from HH10 and HH30 embryo neural tubes or from
FACS-separated cells from dissected shRNA-control or
shRNA-EZH2 electroporated neural tubes was extracted by
TRIZOL (Invitrogen)protocolwith 2 ml of pellet paint co-precipi-
tant (Novagene). Reverse transcription was performed with
Transcriptor kit (Roche), following the manufacturer’s pro-
cedure. qPCR was performed with Sybergreen (Roche) in an
LC480Lightcycler (Roche).GAPDHwasused fornormalization.
4.9. Chromatin immunoprecipitation
shRNA-control or shRNA-EZH2 electroporated neural tubes
were dissected out from HH25 embryos. 2.5 and 1.5 million
cells were used for EZH2 ChIP and H3K27me3 ChIP,respectively, which were run essentially as described elsewhere
[57]. Basically, cellswere fixedwith 1% formaldehyde for 10 min
at room temperature; in addition, for EZH2 ChIP a previous fix-
ation step with 2 mM DSG (Sigma 80424) was performed for
40 min at room temperature. Fixation was quenched with gly-
cine (0.125 M). Fixed cells were lysed in a SDS-containing
buffer (1% SDS; 10 mM EDTA pH 8.0; 50 mM Tris–HCl pH
8.1), and sonication was carried out in a Bioruptor (six cycles,
high power, 30 s ON–30 s OFF) to get DNA fragments of an
average of 500 bp. Chromatin was purified by centrifugation
for 30 min, at 20 000g and 48C. Purified chromatin was further
diluted in immunoprecipitation buffer (0.01% SDS, 1.1% Triton
X-100; 1.2 mM EDTA pH 8.0; 16.7 mM Tris–HCl pH 8.1;
167 mM NaCl). Incubation with the appropriated specific anti-
bodies (EZH2 (AC22), Active Motif and H3K27me3 (07–449),
Millipore) or an unspecific antibody (rabbit IgGs (C15410206),
Diagenode) was performed overnight at 48C. Protein A-bound
beads were added and immunocomplexes were washed once
with buffers TSE I (0.1% SDS; 1% Triton-X100; 2 mM EDTA
pH 8.0; 20 mM Tris–HCl pH 8.1; 150 mM NaCl), TSE II (0.1%
SDS; 1% Triton-X100; 2 mM EDTA pH 8.0; 20 mM Tris–HCl
pH 8.1; 500 mM NaCl) and TSE III (0.25 M LiCl; 1% NP-40;
1% sodium deoxycholate; 1 mM EDTA pH 8.0; 10 mM Tris–
HCl pH 8.1) and twice with TE buffer (10 mM Tris–HCl pH
8.1 and 1 mM EDTA). De-crosslinking was carried out at 658C
in elution buffer (1% SDS, 0.1 M NaHCO3) for 4 h. DNA was
purified by phenol–chloroform followed by ethanol precipi-
tation. Binding of the proteins of interest to the selected
regions was assayed by qPCR in a Lightcycler 480 with SYBR
Green (Roche) with the following primers:
fwp21WAF1/CIP1 GCAGATCCAGAACGACTTTGA; rwp
p21WAF1/CIP1 GGTCTCGAAGTTGAAGTTCCA; fwHes5 TGA
AAGATTGGCAGAGGAAAC; rwHes5 GTACCCATTTCTCAC
TACAGC; fwNeuroD1 GAGGGATTTTAACCACCTTCG;
rwNeuroD1 TCACTTAGCGCGTGATTTACA.
4.10. In vivo luciferase-reporter assay
Chick embryos were electroporated at HH11–12 with the
indicated DNAs together with the p21WAF1/CIP1 promoter
fused to luciferase reporter construct or the reporter plasmid
pSRE-luc containing 5XSRE of the c-fos promoter and a b-
gal-reporter carrying the CMV immediate early enhancer
promoter for normalization. Embryos were harvested after
48 h PE and GFP-positive neural tubes were dissected and
homogenized in Passive Lysis Buffer. Firefly- and b-gal-luci-
ferase activities were measured by the b-gal and luciferase
dual reporter assay (Dual-Lightw Luciferase and b-Galactosi-
dase Reporter Gene Assay System, Life Technologies).
4.11. BrdU incorporation
A total 0.5 mg ml21 BrdU was injected into the lumen of the
neural tube of chick embryos 30 min before fixation. BrdU
was detected on sections by treatment with HCl 2 N for
30 min, neutralization with sodium borate 0.1 M (pH 8.5)
and incubation with anti-BrdU antibody.
4.12. Microarray analysis
Fifteen embryo neural tubes were electroporated with
shRNA-control (shCtrl) or shRNA-EZH2 (shEZH2) for each
of the three replicates. Isolated neural tubes were trypsinized
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replicate. RNAwas extracted and after quality control, quantifi-
cation, reverse transcription and labelling, it was independently
hybridized to Affymetrix Chicken GeneChip using Affymetrix
technology following manufacturer’s instructions at IRB
Barcelona’s Functional Genomics Core Facility. Data analysis
was performed using the GENESPRING software 10.0 (Silicon
Genetics, Redwood City, CA, USA). Raw data from the six
hybridizations were normalized to the 50th percentile per
chip and to the median per gene. Normalized mean values
for the two individual experimental groups (shCtrl and
shEZH2) were generated for the experimental interpretation.
The statistical significance of the differences was evaluated by
using unpaired t-test. Differentially expressed genes were
identified when the absolute FC. 1.5 and p, 0.05.
4.13. Primers used for qPCR
fwEZH2 CTCAATGTTTCCAGATAAGGGT; rwEZH2 GCTG
TTCAGTGAGTTCTTTG; fwGAPDH CGATCTGAACTAC
ATGGTTTAC; rwGAPDH ATCACAAGTTTCCCGTTCTC;
fwp21WAF1/CIP1 CAGACCACCATCAAAGACTTCTA; rwp
21WAF1/CIP1 CTTGGGCTTATCGTGGACAA; fwDNAH3 AA
TACACCATCCCCATTGAC; rwDNAH3 ATTGTGTTCTCCT
GCTTCAT; fwMYOT GCAACACATACAAACAAGCC;
rwMYOT CTTGCTGAAAGTTGGTCGGA; fwFN CCAGTTC
ACACAGAGATACC; rwFNGTGTGTCTGCCTGTACATCTA;
fwDHCR GAAAAGTTTGTGAGAAGCGTG; rwDHCR GGT
CATGTAGCAATCCGCATA; fwTJP2 GAGATGGATCA
TAAGGCAAGAC; rwTJP2 GATGCTTCTGGGCTATTTCAA;
fwNINJ2 CAGGATCTGAACAGCACAAC; rwNINJ2 TCTG
GATTCTTTGCTGGGAT; fwEDNRB GTAATGGACTACATT
GGCATTAAC rwEDNRB TTTGGAATCTCTTGCTCACC;
fwMDM2 AGGAGGACTTCAGGGAAC; rwMDM2 GCTA
ACAGGCAGACTGG; fwSESN1 GAGAAGGAGACCGTTC
AAG; rwSESN1 AAGAGTCCGCAAACAGC; fwCDH5
TTTCCCACACCTGACGTTAC; rwCDH5 TGTCCTAAGAG
ACCCACTTC; fwFOXD3 GCGAGTTCATCAGCAACC;rwFOXD3 GATGCTGTTCTGCCAGG; fwPPP1R1C AGGAG
GAAGAGGGAATCG; rwPPP1R1C AGACTTGCATGGTT
TAGTGG; fwLHX9 GAGAACGAGGCAGATCAC; rwLHX9
CGCTTTGTCTTCTGGGATG; fwPARD3 CCAGGTGAAGG
GTTCCAGAC; rwPARD3 CCCCCATGTAGCCGTTTCTT;
fwaPKC GAGCTGTATGGGAAGCGAGG; rwaPKC CCGC
GGCCTGAAGTTGTTTA; fwCDH2A GCCCACGGAGTTTG
TAGTG; rwCDH2A TGCTGGTTCAGGGGTTAGC; fwEZH1
TTGCCAACCACTCCGTGAA; rwEZH1 TCACCATCACAA
CTTTGGCATAG.
4.14. Statistical analysis
Quantitative data were expressed as mean and standard devi-
ation. Significant differences between groups were tested by
Student’s t-test.
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